Journal of the American Chemical Society 2006-12-27

On the mechanism of an asymmetric alpha,beta-unsaturated carboxylic acid hydrogenation: application to the synthesis of a PGD2 receptor antagonist.

David M Tellers, J Christopher McWilliams, Guy Humphrey, Michel Journet, Lisa DiMichele, Joseph Hinksmon, Arlene E McKeown, Thorsten Rosner, Yongkui Sun, Richard D Tillyer

Index: J. Am. Chem. Soc. 128 , 17063, (2006)

Full Text: HTML

Abstract

Ruthenium complexes employing axially chiral ligands were found to be effective asymmetric hydrogenation catalysts for the reduction of alpha,beta-unsaturated ene acid 1-E to give 2, a prostaglandin D2 (PGD2) receptor antagonist. With [(S-BINAP)Ru(p-cymene)Cl2]2 (3, S-BINAP = (S)-(+)-2,2'-bis(diphenylphospino)-1,1'-binapthyl), it was discovered that low hydrogen pressures (<30 psi) were essential to achieve high enantioselectivities (92% ee). A detailed mechanistic study was undertaken to elucidate this pressure dependence. It was determined that compound 1-E is in a ruthenium-catalyzed equilibrium with endocylic isomer 1-Endo and in photochemical equilibrium with Z isomer 1-Z. Each isomer could be hydrogenated to give 2, albeit with different rates and enantioselectivities. Hydrogenation of 1-Endo with 3 was found to give 2 in high enantiomeric excess, regardless of pressure and at a rate substantially faster than that of hydrogenation of 1-E and 1-Z. In contrast, isomers 1-E and 1-Z exhibited pressure-dependent enantioselectivities, with higher enantiomeric excesses obtained at lower pressures. A rationale for this pressure dependence is described. Deuterium labeling studies with 1-Endo and tiglic acid were used to elucidate the mechanism of hydride insertion and product release from ruthenium. Under neutral conditions, protonolysis was the major pathway for metal-carbon cleavage, while under basic conditions, hydrogenolysis of the metal-carbon bond was predominant.


Related Compounds

Related Articles:

The preparation of bi-functional organophosphine oxides as potential antitumor agents.

2010-11-01

[Eur. J. Med. Chem. 45 , 5527-30, (2010)]

Ohkuma, T. et al.

[J. Am. Chem. Soc. 117 , 2675, (1995)]

Genet, J.-P. et al.

[Tetrahedron Lett. 36 , 2063, (1995)]

Smith, P. et al.

[Synth. Commun. 25 , 1093, (1995)]

R. Noyori, H. Takaya

[Acc. Chem. Res. 23 , 345, (1990)]

More Articles...